ORGANACURE® 100% Organic pure natural usa Sun GROWN HEMP DERIVED CBD company™

SCIENCE AND RESEARCH

    

Cannabinoid Science

Disclaimer: ORGANACURE® makes no claims to diagnose, treat or cure the following conditions. Clinical research, case studies and articles below regarding cannabinoids are for informational purposes only. The following statements have not been approved by the FDA. Please consult your physician to see if ORGANACURE® is right for you.


What is Hemp vs. Cannabis Extract?

Hemp Plant Extract is derived from industrial hemp, according to the Farm Bill of 2014 contains less than .3% THC by dry weight. One of the major phytocannabinoid molecules of hemp is the non-psychoactive counterpart, Cannabidiol “CBD”.  


Cannabis Plant Extract is derived from Marijuana, contains a prominent trace of Tetrahydrocannabinol “THC”, a  psychoactive molecule, and in some strains include ratios of its  non-psychoactive counterpart “CBD” Cannabidiol.


What are Cannabinoids?

A cannabinoid is one of a class of diverse chemical compounds  found within either Cannabis or Industrial Hemp. The most common studied  cannabinoids include:  

  • Tetrahydrocannabinol (THC) 
  • Cannabidiol (CBD) 
  • Cannabinol (CBN)


The Human Endocannabinoid System

The Endocannabinoid system (ECS) is a group of cannabinoid  receptors located in the mammalian brain and throughout the central and  peripheral nervous systems, consisting of neuromodulary lipids and their  receptors.  Known as the bodys endocannabinoid system, the  ECS is  involved in a variety of physiological processes including appetite,  pain sensation, mood and memory and in mediating the psychoactive  effects of cannabis. The ECS is also involved in voluntary exercise and may be related to the evolution of the runners high in human beings and related aspects of motivation or reward for locomotor activity in other animals.

Two primary endocannabinoid receptors have been identified: CB1,  in 1990; and CB2, in 1993. CB1 receptors are found predominantly in the  brain and nervous system, as well as in peripheral organs and tissues,  and are the main molecular target of the endocannabinoid ligand (binding  molecule), Anandamide as well as its mimetic phytocannabinoid,  Tetrahydrocannabinol “THC”. One other main endocannabinoid is  2-Arachidonoylglycerol  (2-AG) which is active at both cannabinoid  receptors, along with its own mimetic phytocannabinoid, Cannabidiol  “CBD”.  2-AG and CBD are involved in the regulation of appetite, immune  system functions and pain management.

Evidence suggests that endocannabinoids may function as both neuromodulators and immunomodulators in the immune system. Here, they  seem to serve an autoprotective role to ameliorate muscle spasms,  inflammation, and other symptoms of multiple sclerosis and skeletal  muscle spasms.

The two most relevant receptors for cannabinoids are the CB1 and  CB2 receptors, which are expressed predominantly in the brain and immune  system respectively. 


Cannabinoid receptor type 1

CB1 receptors are found primarily in the brain, more specifically  in the basal ganglia and in the limbic system, including  the hippocampus and the striatum. They are also found in  the cerebellum and in both male and female reproductive systems.  CB1 receptors are absent in the medulla oblongata, the part of the brain  stem responsible for respiratory and cardiovascular functions.


Cannabinoid receptor type 2

CB2 receptors are predominantly found in the immune system, or  immune-derived cells with the greatest density in the spleen. While  found only in the peripheral nervous system, a report does indicate that  CB2 is expressed by a subpopulation of microglia in the  human cerebellum. CB2 receptors appear to be responsible for the  anti-inflammatory and possibly other therapeutic effects of cannabis  seen in animal models.

ORGANACURE® exclusive hemp genetics. Lab tests available upon request to show less than .3% THC.

ORGANACURE® exclusive hemp genetics. Lab tests available upon request to show less than .3% THC.